Evidence map›Paper›PMID 41126171›Full record

ArticleBMC psychiatry2025

Oxidative stress and cognitive function in Chinese patients with major depressive disorder: the mediating role of depression severity.

Rui-Jie Peng, Chao Sun, Yu Fan, Jin Li, Ju Gao, Wen-Xi Sun, Xiao-Bin Zhang, Qing Tian

Abstract read
In one paragraph

Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Peripheral S-(PGJBMC psychiatry · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rui-Jie Peng *Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, P.R. China.
Chao Sun *Suzhou Medical College of Soochow University, Suzhou, P.R. China.
Yu Fan *Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, P.R. China.
Jin LiSuzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, P.R. China.
Ju GaoSuzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, P.R. China.
Wen-Xi SunSuzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, P.R. China.
Xiao-Bin ZhangSuzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, P.R. China. zhangxiaobim@163.com.
Qing TianSuzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, P.R. China. sunnytien@126.com.

Funding

Science and Technology Program of Suzhou (CN) MSXM2024032Science and Technology Program of Suzhou (CN) SZS2024016Suzhou Municipal Science and Technology Bureau Szlcyxzx202109
6 · The paper itself

Abstract

backgroundOxidative stress is increasingly implicated in the pathophysiology of major depressive disorder (MDD), which is often accompanied by significant cognitive impairments. However, the interplay between oxidative stress markers, cognitive function, and the severity of depression symptom, particularly the potential mediating role of severity, requires further investigation. This study aimed to examine alterations in oxidative stress markers in Chinese patients with MDD, their association with cognitive performance, and whether depression and anxiety severity mediates this relationship.

methodsForty-four patients meeting DSM-5 criteria for MDD and 47 matched healthy controls (CON) were recruited. Cognitive functions were assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Stroop Color-Word Test. Depression and anxiety severity were evaluated using the Hamilton Depression Rating Scale (HAMD-24) and Hamilton Anxiety Rating Scale (HAMA). Plasma levels of oxidative stress markers, including malondialdehyde (MDA) and catalase (CAT), were measured via ELISA. Group comparisons (controlling for education), correlation analyses, and mediation analyses (using bootstrapping) were performed.

resultsCompared to healthy controls, patients with MDD exhibited significantly higher plasma MDA levels (1.9 ± 0.4 vs. 1.6 ± 0.5 nmol/mL, P = 0.025) and lower CAT activity (0.7 ± 0.2 vs. 0.9 ± 0.3 U/mL, P = 0.020). The MDD group showed significant cognitive deficits in immediate memory (P = 0.002), attention (P < 0.001), delayed memory (P = 0.010), and the RBANS total score (P = 0.002). Plasma MDA levels negatively correlated with immediate memory (r = - 0.34, P = 0.033) and delayed memory (r = - 0.36, P = 0.021), and positively correlated with both HAMD (P = 0.041) and HAMA scores (P = 0.048). Mediation analyses revealed that HAMD and HAMA scores significantly mediated the relationship between plasma MDA levels and immediate memory performance (Indirect effect P < 0.05 for both).

conclusionsChinese patients with MDD demonstrate heightened oxidative stress (elevated MDA, reduced CAT) and impaired cognitive function, particularly in memory domains, compared to healthy individuals. Higher levels of oxidative stress marker MDA are associated with greater depression/anxiety severity and poorer memory performance. Furthermore, symptom severity partially mediates the link between oxidative stress and immediate memory deficits, suggesting a complex interplay among these factors in MDD pathophysiology.

Indexed as

Cognitive DysfunctionMajor Depressive DisorderOxidative StressAdultAnxietyBiomarkersCase-Control StudiesCatalaseChinaEast Asian PeopleFemaleHumansMaleMalondialdehydeMiddle AgedNeuropsychological TestsBiomarkersCatalaseMalondialdehydeCognitive functionsDepressionMediating effectsOxidative stress

Identifiers

PMID41126171
PMCPMC12542138

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.